FDA, CDC Name for Break in Johnson & Johnson COVID-19 Vaccine Use As a result of Blood Clot Issues – CBS Pittsburgh

By: KDKA-TV News Staff

PITTSBURGH (KDKA) – Several federal agencies will call for the distribution of Johnson & Johnson’s COVID-19 vaccine to be halted amid concerns about cases of blood clots in women after vaccination.

According to the New York Times, the FDA and CDC will be calling for an immediate halt to the use of the J&J vaccine.

The New York Times says the federal government is expected to halt use of the vaccine at all federal-run vaccination sites and that state health officials will follow suit.

Six women between the ages of 18 and 48 have reportedly developed rare blood clot disorders within two weeks of being vaccinated. One of the women died and a second was hospitalized in Nebraska, according to the Times.

Johnson & Johnson’s vaccine was sold locally in clinics operated by the Allegheny Health Network and UPMC.

It is unclear whether this federal call will affect these clinics.